QurieGen’s Post

Looking forward to be on the judging panel together with the two rockstars Mathilde Lyet and Sofia Randine Svanqvist on Friday Feb 23rd at Techarenan Incubator Stars Challenge! Check out these cool companies that we get to see pitch and join us at 11.30-12.30. 🔆 Exaum, Finland: Accelerating green energy transition by balancing electric grid demand through an AI system that predicts and places automated bids in the energy grid markets. 🔆 Worldish, Sweden: The world's first medical multilingual communication AI assistant, helping patients and healthcare professionals communicate health information safely. 🔆 IPercept, Sweden: AI-based, hardware-enabled software solutions and services that can best be described as the fitness tracker for complex industrial machines. 🔆 Enerpoly, Sweden: Description: Battery innovator that develops and manufactures next-generation batteries using more abundant, globally available materials. 🔆 BrainZell, Sweden: Lab-grown mini-brains for safer pharmaceuticals. Stem cell-based models that better match the human brain than those of animals. 🔆 TeraSi, Sweden: Compact components for 6G - the next generation of wireless technology - and beyond. TeraSi's mission is to enable a wireless future by bringing its technology to the masses. 🔆 Stardots, Sweden: Deep-tech digital therapeutics platforms for optimised treatment of various diseases with an initial focus on Parkinsons disease. Can't wait to see what you have put together. It's going to be a blast! Omid Ekhlasi, Mikaela Larsell Ayesa, Jens Ingelstedt, Linda Nyberg, Johannes Netzén, Ellen Bjerkehag, Ibrahim Naji

As part of the Rejuvenation Startup Summit 2024 by Forever Healthy, I was fortunate to lead an interview with the pioneer and leading expert in the field of Therapeutic Apheresis and longevity, Dobri Kiprov.   🔬 Key Highlights: - Experience in #Plasmapheresis: Dobri Kiprov has been in the field of plasmapheresis for about 40 years. - Origin of the Idea: The idea for using plasmapheresis for rejuvenation originated from mouse experiments at Stanford University, which involved exchanging blood between young and old mice and observing tissue and brain changes. - Plasma Exchange Process: The procedure involves replacing old plasma with new plasma and albumin, a major protein in plasma with potent anti-inflammatory and antioxidant properties. - Rejuvenation of organs: The process helps different organs become biologically younger, which is crucial for preventing diseases associated with aging. - Significant Results: The most notable outcome is the decrease in biological age, with patients experiencing younger organ functions and overall rejuvenation, supported by various tests and testimonials.   This conversation dives deep into the science and potential of plasma exchange. Benefit from Dobri Kiprov’s expertise on this topic.  . 👀 Watch the full video and join the conversation! Let’s explore the future of aging together. 💬 Your thoughts? Share your comments and let’s discuss the possibilities! 🖤 Our heartfelt thanks goes out to Frank Schueler for his support at the RSS and to Kizoo Ventures and Michael Greve.   #longevity #dobrikiprov #plasmatransfer #bloodexchange #RejuvenationStartupSummit2024

Great to be recognized for the innovative work my colleagues are doing at VEIR to increase transmission capacity over conventional conductors by 5 to 10x with our superconductors. #superconductors #gridmodernization #innovation

Less than 3 weeks till the start of the world’s leading conference in longevity space -- #ARDD2024! 🚀 Already traditional, the 11th Aging Research and Drug Discovery Conference will gather drug discovery, biotech, and aging research minds from across the globe in a campus of the Københavns Universitet - University of Copenhagen . This year’s ARDD will feature Longevity Medicine Track, Emerging Science & Technologies Workshop, and Physics in Aging Biology Workshop, among others. Some of the key themes this year: ✅ latest advancements in molecular and cellular mechanisms of aging, ✅ biomarkers of aging, and age-related diseases, ✅ translating these findings into clinical applications. One of the cool features of the 2024 event is that it will host the inaugural XPRIZE Healthspan Team Summit. It is part of a $101 million global competition aimed at revolutionizing therapeutic approaches to aging by extending muscle, cognition, and immune function. I will also be judging the Startup Pitch session on Thursday, August 29th and I think this is a particularly great chance for ambitious startups in drug discovery, biotech, or longevity fields to get in front of not only our fund, LongeVC but also other investors, mentors, and potential clients. The Startup Pitch panel will be moderated by Jitka Kolarova, Lead for Innovations in Health and Healthcare at World Economic Forum, and other judges include: Katerina Stroponiati - Founder of Brilliant Minds Jens Nielsen - CEO at BioInnovation Institute Reach out to us at BAKULA@sund.ku.dk for more information on how to participate. Or DM me if you are interested specifically in opportunities with LongeVC or myself. Don't miss this opportunity to shine at the world's leading longevity event hashtag#ARDD2024 and take your startup to the next level! 🚀 #StartupPitch #agingresearch #longevity #venturecapital Alex Zhavoronkov Morten Scheibye-Knudsen Daniela Bakula Evelyne Bischof, MD, PhD Longevity Science Foundation Image credit: ARDD

Introducing the next team on the Venture Challenge journey! 🌱 From May 6 to June 28, six teams of starting entrepreneurs dive into the complexities of developing and presenting a robust business plan. Let's shine the spotlight on our next team: 💪 Myonovum 2.0 - Redefining neuromuscular drug development 💪 Left to right: Jelle Eikelhof, Lisa Kleinjan, Alessandro Iuliano Building on a unique three-dimensional in vitro muscle model methodology developed within Erasmus MC, Myonovum 2.0 offers advanced analysis services to pharmaceutical and biotech companies. They specialize in creating human induced pluripotent stem cells (hiPSCs)-derived myogenic cell lines of superior quality, leading to the creation of high-quality 3D Tissue Engineered Skeletal Muscles (3D-TESMs). These models serve as human in vitro muscle platforms for disease modeling and drug testing, significantly expediting the development of improved therapies and therapeutic strategies. Learn more: https://lnkd.in/ekSvKhru Stay tuned as we continue to unveil the ventures of each team participating in the Venture Challenge Spring 2024! Together, we're shaping the future of the life sciences industry. 💡 Pivot Park, Loyens & Loeff Life Sciences Team, NWO (Nederlandse Organisatie voor Wetenschappelijk Onderzoek), Ministerie van Economische Zaken en Klimaat, Health~Holland, GameChanger Challenge Picture by: Eyequote | fotografie + beeldbewerking

The ULS23 challenge is well progressing, with 400+ researchers and 17 teams working on pushing the boundaries of Universal Lesion Segmentation. With five weeks left, there's still time to contribute before the March 31 deadline. The top 3 teams surpassing the baseline model will get to co-author the challenge's evaluation paper, showcasing their work on this important medical problem. Here's a brief overview of what makes the ULS23 challenge worth participating in: ➡️ Comprehensive Training Dataset: including more than 39,000 lesions from 13 different sources, offering a wide range of lesion types for analysis. ➡️ Mixed Supervision: The challenge features both fully and weakly annotated lesions, providing a unique challenge to participants. ➡️ Thorough Evaluation: Using a diverse, multi-center test set curated for ULS, we ensure a detailed and fair assessment of the developed models. ➡️ Open Solutions: The algorithms developed during the challenge will be shared on the Grand Challenge platform, making them available to the broader research community. ℹ Challenge website: https://lnkd.in/eceHYX9n Can't wait for the solutions of the participants? You can already try out our baseline model on your own data on Grand Challenge: https://lnkd.in/ebQJAcCR Kudos to Max de Grauw for this amazing organisation!

Weizmann alumni make their impact everywhere: in the academia, in the world of entrepreneurship, and in the business sector in just about every aspect that improves human life. But beyond gaining exceptional research experience, being a student at Weizmann is about making friends, who later become colleagues and partners in the lifetime journey of the scientific career.  https://lnkd.in/dC7B4ted #weizmannalumni #WeizmannInstituteofScience

Weizmann alumni make their impact everywhere: in the academia, in the world of entrepreneurship, and in the business sector in just about every aspect that improves human life. But beyond gaining exceptional research experience, being a student at Weizmann is about making friends, who later become colleagues and partners in the lifetime journey of the scientific career.  https://lnkd.in/dZg8Sn39

Our funded research got published! 📚🔬 congratulations to Vaijayanti Gupta , Vijay Chandru and team. Check out the groundbreaking findings that will contribute to advancing knowledge in CRISPR SARS- CoV-2 test in wastewater sample. 🌐 #Research #Publication #Team CRISPR-based SARS-CoV-2 test not only swiftly identifies the virus in a few hours at the bedside but also distinguishes its variants in the same timeframe. 💡 Addressing a critical issue from the first wave, this test bridges the gap between rapid virus detection and variant confirmation, preventing cross-infections in hospitals. 🏥 This assay is a game-changer, offering a rapid and efficient solution to detect virus variants in wastewater, contributing to public health. 🌍🔬 #COVID19 #Research #Innovation #PublicHealth

🌟 *My Journey with Nano 24: From a Dream to Life-Changing Reality* Hello, dear LinkedIn community! Today, I want to open my heart and share with you the story of Nano 24, a journey that is not just mine, but one that could change the lives of many. 🔬 *The Birth of EXO-CD24: A Personal Mission* It all started with a vision to create a world where respiratory and systemic diseases could be treated more effectively and compassionately. With the development of EXO-CD24, alongside the brilliant minds of Prof. Nadir Arber and Dr. Shiran Shapira, we're turning this vision into a reality. This drug is not just a scientific breakthrough; it's a beacon of hope for countless individuals, offering an innovative alternative to steroids without the harsh side effects. 💼 *A Call to Action:* Join Our Cause Today, I extend a personal invitation to you to join us in this journey. We're opening an investment opportunity starting at ₪100,000 through a SAFE investment. This isn't just an investment in a company, but a commitment to a healthier, brighter future. ✨*Our Triumphs: A Testament to Our Commitment* • We've successfully navigated the first stage of FDA approval. • EXO-CD24 has shown remarkable results in over 180 patients. • Our collaboration with Ichilov Hospital has been a cornerstone in our development and patient care. • Recognition and support from the Innovation Authority. • Investment from two major biotech venture capital funds: Woodbury and Sammy Segol's fund. 🌱 *Focusing on ARDS:* A Step Towards a Greater Goal Our initial focus with EXO-CD24 is on combating ARDS, aiming to drastically improve the quality of life for those affected. 🔗 *Be Part of Our Story* I invite you to learn more about our mission and consider becoming part of our story. Visit our campaign page https://lnkd.in/dUiAUtKJ more details. Your support could be the key to unlocking a new era in healthcare. Together, let's make a difference. Let's bring hope and healing to the world with Nano 24.